Memory Pharmaceuticals Corp.

Memory Pharmaceuticals is focused on developing innovative drugs for the treatment of debilitating central nervous system (CNS) disorders, many of which exhibit significant impairment of memory and other cognitive function.

Memory Pharmaceuticals is now a wholly owned subsidiary of Roche.